Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novavax Inc (NVAX)

Novavax Inc (NVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,870,771
  • Shares Outstanding, K 73,859
  • Annual Sales, $ 475,600 K
  • Annual Income, $ -418,260 K
  • 60-Month Beta 1.48
  • Price/Sales 30.23
  • Price/Cash Flow N/A
  • Price/Book 17.83
Trade NVAX with:

Options Overview

Details
  • Implied Volatility 112.14%
  • Historical Volatility 83.61%
  • IV Percentile 22%
  • IV Rank 29.79%
  • IV High 180.97% on 04/21/20
  • IV Low 82.93% on 11/11/20
  • Put/Call Vol Ratio 0.42
  • Today's Volume 18,011
  • Volume Avg (30-Day) 13,060
  • Put/Call OI Ratio 0.62
  • Today's Open Interest 161,027
  • Open Int (30-Day) 98,685

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -2.65
  • Number of Estimates 4
  • High Estimate -1.02
  • Low Estimate -3.74
  • Prior Year -0.58
  • Growth Rate Est. (year over year) -356.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
159.09 +26.56%
on 03/25/21
241.48 -16.62%
on 03/22/21
-1.43 (-0.71%)
since 03/12/21
3-Month
121.26 +66.04%
on 01/20/21
331.68 -39.30%
on 02/09/21
+71.36 (+54.90%)
since 01/14/21
52-Week
16.41 +1,126.93%
on 05/01/20
331.68 -39.30%
on 02/09/21
+183.34 (+1,018.56%)
since 04/14/20

Most Recent Stories

More News
Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

, /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its participation in a newly expanded investigator-initiated...

NVAX : 201.34 (+3.43%)
Thinking about trading options or stock in Tesla, Moderna, Novavax, Snap, or Nio?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TSLA, MRNA, NVAX, SNAP, and NIO.

MRNA : 160.03 (+6.89%)
NVAX : 201.34 (+3.43%)
TSLA : 732.23 (-3.95%)
NIO : 37.02 (-3.79%)
SNAP : 62.01 (-0.69%)
S&P Reaches New Record Ahead of Big Bank Reports

S&P Reaches New Record Ahead of Big Bank Reports

JPM : 151.21 (-1.87%)
WFC : 41.99 (+5.53%)
GS : 335.35 (+2.34%)
VMC : 174.08 (+0.83%)
AXLA : 4.35 (-6.65%)
NVAX : 201.34 (+3.43%)
TWST : 142.03 (+0.87%)
TAL : 57.96 (-1.55%)
ILMN : 398.07 (-1.26%)
NEO : 49.19 (-0.65%)
HTHT : 55.94 (+1.18%)
LVS : 61.31 (+0.51%)
TDC : 39.37 (-0.73%)
JNJ : 159.92 (+0.28%)
Novavax Announces Leadership Updates

, /PRNewswire/ --  Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the promotion of , Ph.D., to Senior Vice...

NVAX : 201.34 (+3.43%)
Thinking about trading options or stock in Zai Lab, Novavax, Johnson & Johnson, Marathon Digital, or Riot Blockchain?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZLAB, NVAX, JNJ, MARA, and RIOT.

NVAX : 201.34 (+3.43%)
ZLAB : 164.83 (+2.19%)
MARA : 42.97 (-15.75%)
RIOT : 50.16 (-15.36%)
JNJ : 159.92 (+0.28%)
Heading Into Earnings Season with Dow and S&P at Record Highs

Heading Into Earnings Season with Dow and S&P at Record Highs

JPM : 151.21 (-1.87%)
WFC : 41.99 (+5.53%)
C : 72.91 (+1.18%)
BAC : 39.88 (+1.42%)
ALLY : 47.75 (+1.68%)
PNC : 179.34 (+0.97%)
MS : 80.79 (+1.58%)
NVAX : 201.34 (+3.43%)
GTBP : 9.63 (+0.63%)
HIMX : 12.79 (-1.69%)
Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know

Novavax (NVAX) closed at $179.74 in the latest trading session, marking a +1.97% move from the prior day.

NVAX : 201.34 (+3.43%)
Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

AZN : 49.84 (+1.32%)
PFE : 37.17 (+0.03%)
MRNA : 160.03 (+6.89%)
NVAX : 201.34 (+3.43%)
IBB : 151.34 (+1.43%)
XBI : 132.32 (+2.65%)
BBH : 180.28 (+0.88%)
FBT : 160.39 (+0.92%)
BTEC : 58.14 (+1.87%)
BNTX : 132.60 (+2.28%)
Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference

, /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat...

NVAX : 201.34 (+3.43%)
Company News for Apr 7, 2021

Companies in The News Are: ILMN, NVAX, MRNA, BP.

ILMN : 398.07 (-1.26%)
MRNA : 160.03 (+6.89%)
BP : 25.54 (+3.74%)
NVAX : 201.34 (+3.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases. Their technology platforms involve the use of proprietary, microscopic, organized, non-phospholipid structures as...

See More

Key Turning Points

3rd Resistance Point 224.93
2nd Resistance Point 218.23
1st Resistance Point 209.79
Last Price 201.34
1st Support Level 194.65
2nd Support Level 187.95
3rd Support Level 179.51

See More

52-Week High 331.68
Fibonacci 61.8% 211.25
Last Price 201.34
Fibonacci 50% 174.04
Fibonacci 38.2% 136.84
52-Week Low 16.41

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar